• 07 Mar, 2026

The Union Budget 2026–27 marks a major shift in India’s healthcare policy with the announcement of three All-India Institutes of Ayurveda, 24×7 trauma centres in every district hospital, integrated medical hubs, Biopharma Shakti funding, expansion of clinical trials and large-scale allied healthcare workforce training.

Union Budget 2026–27: Three New National Ayurveda Institutes and a Broader Health Push

The Union Budget 2026–27 marks a significant moment for India’s healthcare sector, with total health spending crossing ₹1,04,599 crore for the first time. The government’s approach this year focuses on expanding healthcare infrastructure, strengthening human resources, boosting domestic drug manufacturing, and formally integrating traditional systems of medicine into the national health framework.

Announcement of three All-India Institutes of Ayurveda

A major highlight of the Budget is the announcement of three new All-India level Institutes of Ayurveda, envisioned on the lines of premier national institutions. These institutes are intended to function as centres of excellence for education, advanced clinical care, and research in Ayurveda. The move reflects a policy shift towards institutionalising Ayurveda with structured training, national standards, and stronger academic credibility.

Why national-level Ayurveda institutes matter

The establishment of three national Ayurveda institutes has multiple implications. It expands postgraduate and research opportunities in Ayurveda, creates a structured ecosystem for evidence-based practice, and supports standardisation of treatments and formulations. National institutes also act as referral centres and academic hubs, which is essential if traditional medicine is to be integrated meaningfully with mainstream healthcare rather than functioning in isolation.

Integrated general medical hubs for multidisciplinary care

The Budget also announces the development of five integrated general medical hubs across the country. These hubs will bring together Ayurveda, Yoga, diagnostics, and recovery services under one roof. The idea is to move towards a multidisciplinary model of care where preventive, rehabilitative, and therapeutic services coexist, rather than operating as fragmented systems.

Trauma and emergency care centres in every district hospital

One of the most critical public health announcements is the plan to establish 24×7 emergency and trauma care centres in all district hospitals. This has the potential to significantly reduce trauma-related mortality, especially in semi-urban and rural areas where access to timely emergency care remains limited. Strengthening district hospitals also reduces the burden on tertiary centres and improves overall referral efficiency.

Strengthening Ayurveda infrastructure and quality control

Alongside new institutes, the Budget proposes upgradation of Ayush pharmacies and drug testing laboratories. This is a crucial step, as quality assurance, standardisation, and pharmacovigilance are essential for patient safety and for improving the credibility of Ayurvedic medicines, especially in the context of global acceptance.

Biopharma Shakti mission and domestic drug manufacturing

Beyond traditional medicine, the Budget introduces the Biopharma Shakti mission, with an investment of ₹10,000 crore over the next five years. The mission aims to strengthen India’s biopharmaceutical sector and ensure that medicines for high-burden diseases such as diabetes and autoimmune disorders are manufactured domestically. This initiative aligns with long-term goals of affordability, self-reliance, and supply chain security.

Three new national drug research institutes

To support innovation and research, the government has announced three new National Institutes for Pharmaceutical Education and Research, along with the upgradation of seven existing institutes. These institutions are expected to play a key role in advanced drug research, regulatory science, and development of new therapies.

Expansion of India’s clinical trial ecosystem

The Budget also proposes the creation of a nationwide Indian Clinical Trials Network, comprising more than 1,000 accredited clinical trial sites. This move aims to strengthen India’s position in global clinical research, improve ethical oversight, accelerate trials, and provide patients with earlier access to emerging therapies.

Allied healthcare workforce expansion

A significant but often underemphasised component of the Budget is the focus on allied healthcare professionals. The government plans to upgrade existing allied health institutions and establish new training centres to train one lakh allied health professionals over the next five years. Training will cover disciplines such as radiology technology, anaesthesia technology, optometry, operation theatre technology, applied psychology, and behavioural health. This investment is critical for improving service delivery, addressing workforce shortages, and reducing the clinical load on doctors.

What remains unclear

While the announcements signal strong intent, key details such as locations of the new Ayurveda institutes, implementation timelines, staffing models, and accreditation frameworks have not yet been specified. The real impact will depend on execution, funding continuity, curriculum standards, and integration with existing health systems.

Final perspective

The Union Budget 2026–27 reflects an attempt to balance traditional medicine, modern biopharma, emergency care, and workforce expansion within a single health vision. If implemented with transparency, scientific rigour, and accountability, the combined push for Ayurveda institutes, trauma care centres, biopharma manufacturing, clinical research, and allied health training could meaningfully strengthen India’s healthcare delivery system. The coming months will determine whether these announcements translate into functional institutions or remain policy headlines.

Dr. Dheeraj Maheshwari

MBBS, PGDCMF (MNLU), MD (Forensic Medicine)